Implantation or Injectable Dosage Form New Animal Drugs; Xylazine Injection
other · US Department of Health and Human Services · Rule · Published 1995-07-06 · Effective 1995-07-06 · 60 FR 35123
Document
Document number
95-16626
Federal Register citation
60 FR 35123
CFR reference
21 CFR 522
Type
Rule
Action
Final rule.
Category
other
Sub-agency
US Department of Health and Human Services
Publication date
1995-07-06
Effective date
1995-07-06
Abstract
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Lloyd, Inc. The supplemental NADA provides for intramuscular use in Cervidae spp. of xylazine injection to produce sedation accompanied by a shorter period of analgesia.